JH

J. Jeffry Howbert

EL Eli Lilly: 26 patents #77 of 2,858Top 3%
QG Qiagen Genomics: 5 patents #2 of 6Top 35%
VP Ventirx Pharmaceuticals: 3 patents #6 of 18Top 35%
CL Celltech R&D Limited: 2 patents #35 of 99Top 40%
AB Array Biopharma: 1 patents #256 of 335Top 80%
US Ucb S.A.: 1 patents #92 of 218Top 45%
Overall (All Time): #86,908 of 4,157,543Top 3%
38
Patents All Time

Issued Patents All Time

Showing 25 most recent of 38 patents

Patent #TitleCo-InventorsDate
9216192 Toll-like receptor agonist formulations and their use Muralikrishna Duvvuri, Robert Hershberg, Gregory Dietsch 2015-12-22
8314090 Methods of synthesis of benzazepine derivatives Venkat Kusukuntla, Alexander Tretyakov, Nathan Nielsen, Pavel Krasik, Ji Jiang +1 more 2012-11-20
8242106 Toll-like receptor agonist formulations and their use Muralikrishna Duvvuri, Robert Hershberg, Gregory Dietsch 2012-08-14
7176310 Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents Theodore A. Baughman, Jim P. Boyce, Ihab Darwish, Nathan Ihle, Randy W. Jackson +3 more 2007-02-13
6906046 Pharmaceutical uses and synthesis of benzobicyclooctanes Randy W. Jackson, Ihab Darwish, Ted Baughman 2005-06-14
6869957 Non-peptide tachykinin receptor antagonists Sung Y. Cho, Thomas Alan Crowell, Bruce D. Gitter, Philip Arthur Hipskind, Joseph H. Krushinski, Jr. +3 more 2005-03-22
6815212 Methods and compositions for enhancing sensitivity in the analysis of biological-based assays Jeffrey Van Ness, John Tabone, John T. Mulligan 2004-11-09
6815214 Pharmaceutical uses and synthesis of diketopiperazines Jim P. Boyce, John Tabone 2004-11-09
6727255 Piperidinyl and piperazinyl tachykinin receptor antagonists Sung Y. Cho, Thomas Alan Crowell, Bruce D. Gitter, Philip Arthur Hipskind, Joseph H. Krushinski, Jr. +3 more 2004-04-27
6623928 Methods and compositions for determining the sequence of nucleic acid molecules Jeffrey Van Ness, John Tabone, John T. Mulligan 2003-09-23
6613508 Methods and compositions for analyzing nucleic acid molecules utilizing sizing techniques Jeffrey Van Ness, John Tabone, John T. Mulligan 2003-09-02
6562862 Methods of inhibiting physiological conditions associated with an excess of neuropeptide Y Robert F. Bruns, Jr., Donald R. Gehlert, William H. W. Lunn 2003-05-13
6444422 Computer method and system for correlating data Jeffrey Van Ness, John Tabone, John T. Mulligan 2002-09-03
6403577 Hexamethyleneiminyl tachykinin receptor antagonists Sung Y. Cho, Thomas Alan Crowell, Bruce D. Gitter, Philip Arthur Hipskind, Joseph H. Krushinski, Jr. +3 more 2002-06-11
6312893 Methods and compositions for determining the sequence of nucleic acid molecules Jeffrey Van Ness, John Tabone, John T. Mulligan 2001-11-06
6175013 Imidazolinyl tachykinin receptor antagonists Philip Arthur Hipskind, Brian S. Muehl 2001-01-16
6147115 Antitumor compositions and methods of treatment Thomas Alan Crowell, John S. Ward 2000-11-14
6027890 Methods and compositions for enhancing sensitivity in the analysis of biological-based assays Jeffrey Van Ness, John Tabone, John T. Mulligan 2000-02-22
5684033 Non-peptide tachykinin receptor antagonists Sung Y. Cho, Thomas Alan Crowell, Bruce D. Gitter, Philip Arthur Hipskind, Joseph H. Krushinski, Jr. +3 more 1997-11-04
5670499 Non-peptide tachykinin receptor antagonists Sung Y. Cho, Thomas Alan Crowell, Bruce D. Gitter, Philip Arthur Hipskind, Joseph H. Krushinski, Jr. +3 more 1997-09-23
5663192 Heterocyclic neuropeptide Y receptor antagonists Robert F. Bruns, Jr., Donald R. Gehlert, William H. W. Lunn 1997-09-02
5643926 Pyrazolidinone CCK and gastrin antagonists and pharmaceutical formulations thereof Raymond F. Brown, Karen L. Lobb, David Andrew Neel, Jon K. Reel, Beverley Greenwood 1997-07-01
5594028 Anti-tumor method and compounds Richard Waltz Harper, Gerald A. Poore, Brent J. Rieder, Eddie V. P. Tao, James A. Aikins 1997-01-14
5576337 Method of treating anxiety by inhibiting physiological conditions associated with an excess of neuropeptide Y Robert F. Bruns, Jr., Donald R. Gehlert, William H. W. Lunn 1996-11-19
5567715 Methods of treating depression by inhibiting physiological conditions associated with an excess of neuropeptide Y Robert F. Bruns, Jr., Donald R. Gehlert, William H. W. Lunn 1996-10-22